John Vlachonikolis

649 total citations
20 papers, 535 citations indexed

About

John Vlachonikolis is a scholar working on Oncology, Pulmonary and Respiratory Medicine and Pathology and Forensic Medicine. According to data from OpenAlex, John Vlachonikolis has authored 20 papers receiving a total of 535 indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Oncology, 6 papers in Pulmonary and Respiratory Medicine and 4 papers in Pathology and Forensic Medicine. Recurrent topics in John Vlachonikolis's work include Lung Cancer Treatments and Mutations (6 papers), Cancer Treatment and Pharmacology (5 papers) and Lung Cancer Research Studies (3 papers). John Vlachonikolis is often cited by papers focused on Lung Cancer Treatments and Mutations (6 papers), Cancer Treatment and Pharmacology (5 papers) and Lung Cancer Research Studies (3 papers). John Vlachonikolis collaborates with scholars based in Greece, Sweden and Iceland. John Vlachonikolis's co-authors include Anthony Kafatos, Daphne Kounali, George Mamalakis, Nikolaos Nikolakakis, John Souglakos, George Samonis, S. Kakolyris, Marina Vakaki, Vassilis Georgoulias and Anthony Kafatos and has published in prestigious journals such as Journal of Clinical Oncology, American Journal of Clinical Nutrition and Cancer.

In The Last Decade

John Vlachonikolis

20 papers receiving 512 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
John Vlachonikolis Greece 13 251 167 140 76 69 20 535
Geneviève Macquart‐Moulin France 10 311 1.2× 243 1.5× 100 0.7× 102 1.3× 119 1.7× 16 701
Xiao-Ou Shu United States 10 169 0.7× 213 1.3× 85 0.6× 76 1.0× 61 0.9× 13 663
J Staszewski France 11 255 1.0× 159 1.0× 159 1.1× 71 0.9× 88 1.3× 25 670
S Tanneberger Italy 10 133 0.5× 114 0.7× 74 0.5× 34 0.4× 28 0.4× 34 356
Roberto Rivera‐Luna Mexico 16 176 0.7× 326 2.0× 77 0.6× 80 1.1× 53 0.8× 67 808
G H Reaman United States 13 160 0.6× 503 3.0× 96 0.7× 25 0.3× 74 1.1× 17 915
Mohammed Khattab Morocco 12 106 0.4× 156 0.9× 65 0.5× 41 0.5× 39 0.6× 30 588
Martin Ahlgren Denmark 8 287 1.1× 147 0.9× 43 0.3× 38 0.5× 24 0.3× 9 680
D B Thomas United States 11 336 1.3× 215 1.3× 50 0.4× 25 0.3× 112 1.6× 17 731
A P Mirra Brazil 6 626 2.5× 94 0.6× 58 0.4× 34 0.4× 77 1.1× 9 915

Countries citing papers authored by John Vlachonikolis

Since Specialization
Citations

This map shows the geographic impact of John Vlachonikolis's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by John Vlachonikolis with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites John Vlachonikolis more than expected).

Fields of papers citing papers by John Vlachonikolis

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by John Vlachonikolis. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by John Vlachonikolis. The network helps show where John Vlachonikolis may publish in the future.

Co-authorship network of co-authors of John Vlachonikolis

This figure shows the co-authorship network connecting the top 25 collaborators of John Vlachonikolis. A scholar is included among the top collaborators of John Vlachonikolis based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with John Vlachonikolis. John Vlachonikolis is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Souglakos, John, Charalambos Kouroussis, Stylianos Kakolyris, et al.. (2002). Nonneutropenic febrile episodes associated with docetaxel‐based chemotherapy in patients with solid tumors. Cancer. 95(6). 1326–1333. 11 indexed citations
2.
3.
Georgoulias, Vassilis, George Samonis, E. Papadakis, et al.. (2001). Comparison of docetaxel/cisplatin to docetaxel/gemcitabine as first-line treatment of advanced non-small cell lung cancer: early results of a randomized trial. Lung Cancer. 34. 47–51. 29 indexed citations
4.
Lionis, Christos, et al.. (2001). Managing Alzheimerʼs Disease in Primary Care in Crete, Greece. Quality Management in Health Care. 9(2). 16–21. 4 indexed citations
5.
Kanavaros, Panagiotis, Kalliopi Stefanaki, John Vlachonikolis, et al.. (2001). Immunohistochemical expression of the p53, p21/Waf-1, Rb, p16 and Ki67 proteins in multiple myeloma.. PubMed. 20(6B). 4619–25. 17 indexed citations
6.
Giannakakis, T., Stylianos Kakolyris, Dimitriοs Mavroudis, et al.. (2000). Docetaxel in combination with carboplatin for the treatment of advanced non-small cell lung carcinoma. European Journal of Cancer. 36(6). 742–747. 11 indexed citations
7.
Kotsakis, Αthanasios, Michael I. Koukourakis, Stella Apostolaki, et al.. (2000). Docetaxel-induced lymphopenia in patients with solid tumors. Cancer. 89(6). 1380–1386. 39 indexed citations
8.
Tamiolakis, D, et al.. (2000). Quantitative cytology in ovarian carcinoma ascitic fluids.. PubMed. 22(2). 139–42. 1 indexed citations
9.
Mazonakis, Michalis, Dimitriοs Mavroudis, John Vlachonikolis, et al.. (2000). Phase I/II study of gemcitabine combined with cisplatin weekly and concurrent thoracic MV-radiotherapy for patients with stage IIIA/B non small cell lung cancer (NSCLC). Lung Cancer. 29(1). 160–160. 6 indexed citations
10.
Kanavaros, Panagiotis, Katerina Stefanaki, John Vlachonikolis, et al.. (2000). Expression of p53, p21/waf1, bcl-2, bax, Rb and Ki67 proteins in Hodgkin's lymphomas.. PubMed. 15(2). 445–53. 31 indexed citations
11.
Kanavaros, Panagiotis, Kalliopi Stefanaki, Kalliope Valassiadou, et al.. (1999). Expression of p53, p21/waf, bcl-2, bax, Rb and Ki67 proteins in colorectal adenocarcinomas. Medical Oncology. 16(1). 23–30. 21 indexed citations
12.
Kouroussis, Charalambos, N. Androulakis, S. Kakolyris, et al.. (1999). Dose-Escalation Study of Docetaxel in Combination With Mitoxantrone as First-Line Treatment in Patients With Metastatic Breast Cancer. Journal of Clinical Oncology. 17(3). 862–862. 18 indexed citations
13.
14.
Kourousis, C., N. Androulakis, S. Kakolyris, et al.. (1998). First-line treatment of advanced nonsmall cell lung carcinoma with docetaxel and vinorelbine. Cancer. 83(10). 2083–2090. 37 indexed citations
15.
Kourousis, C., Nikolaos Androulakis, Stylianos Kakolyris, et al.. (1998). First-line treatment of advanced nonsmall cell lung carcinoma with docetaxel and vinorelbine.. PubMed. 83(10). 2083–90. 45 indexed citations
16.
Kafatos, Anthony, et al.. (1997). Heart disease risk-factor status and dietary changes in the Cretan population over the past 30 y: the Seven Countries Study. American Journal of Clinical Nutrition. 65(6). 1882–1886. 129 indexed citations
17.
Vlachonikolis, John, et al.. (1997). Quantitative pathology in uterine smooth muscle tumours: the case for the standard histologic classification criteria.. PubMed. 18(3). 203–7. 1 indexed citations
18.
Kanavaros, Panagiotis, et al.. (1996). Morphologic Differences between Latent Membrane Protein-1 (LMP-1)-Positive and Negative Tumour Cells in Epstein-Barr Virus (EBV)-Related Childhood Hodgkin's Disease. Pathology - Research and Practice. 192(3). 210–214. 1 indexed citations
19.
Kafatos, Anthony, et al.. (1993). Nutrition status of the elderly in Anogia, Crete, Greece.. Journal of the American College of Nutrition. 12(6). 685–692. 13 indexed citations
20.
Kafatos, Anthony, et al.. (1991). The effects of a health education intervention program among Cretan adolescents. Preventive Medicine. 20(6). 685–699. 67 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Geneviève Macquart‐Moulin Breakdown of academic impact, for papers by Xiao-Ou Shu Breakdown of academic impact, for papers by J Staszewski Breakdown of academic impact, for papers by S Tanneberger Breakdown of academic impact, for papers by Roberto Rivera‐Luna Breakdown of academic impact, for papers by G H Reaman Breakdown of academic impact, for papers by Mohammed Khattab Breakdown of academic impact, for papers by Martin Ahlgren Breakdown of academic impact, for papers by D B Thomas Breakdown of academic impact, for papers by A P Mirra
Rankless by CCL
2026